Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 24, 2017
Pharmacy Choice - Pharmaceutical News - Modi govt plan on generic drugs makes pharma companies, doctors jittery [Syrian Arab News Agency] - April 24, 2017

Pharmacy News Article

 4/19/17 - Modi govt plan on generic drugs makes pharma companies, doctors jittery [Syrian Arab News Agency]

To make health care affordable in the country, the Narendra Modi-led central government is looking to make it mandatory for doctors to prescribe generic drugs. As reported earlier, the health ministry, in line with Finance Minister Arun Jaitleys Union Budget announcement, has started work on amending the Drugs and Cosmetics Act.

After the Act has been amended, doctors will not be allowed to mention brand names in their prescriptions. Instead, they will have to mention the generic name of a drug. The prime ministers Monday announcement on this has made the pharmaceutical industry jittery. Generic drugs` share of the market, 80 per cent at present (20 per cent is accounted for by branded and patented drugs), is expected to go up to 90 per cent in the next three years.

The managing director of a domestic pharmaceutical company who does not wish to be named says the move is a serious one and will shift the thrust from quality to price.

Some industry veterans view this from the angle of marketing ethics. Veeramani, formerly the president of the Indian Drug Manufacturers` Association (IDMA), says the move will keep a check on doctors and ensure the medical fraternity doesnt favour any company. However, he fears the problem will now shift from the doctors desk to the chemists. Now, (since the doctor will mention only the generic name of a drug on the prescription), the chemist might sell medicines that suit him the best. He might push those that yield him better profits. There are over 800,000 chemists in India.

The pharma industry, meanwhile, does not seem enthused. Industry players believe the idea will complicate things for doctors and be very difficult to implement. Doctors may face difficulty in prescribing combination drugs or medicines with multiple ingredients, analysts say.

We do not think making generic prescriptions mandatory will make drugs cheaper. A drug manufactured by a top company will still carry a premium to one that is produced by a less-known company. While the budget does not make it very clear, we believe the amendment might be meant to make generic prescriptions mandatory. Prima facie, it is a negative step. I think the government might be able to introduce it in its own hospitals, but how will it be implemented at a country-wide level is difficult to understand, D G Shah, secretary-general, Indian Pharmaceutical Alliance, had said after the budget announcement.

Dr S S Agarwal, former president, Indian Medical Association, says: While the idea of only prescribing generics is good, it is not practical in India. The doctors job will now be only to diagnose the ailment. Using standard procedures of treatment for an ailment, the chemist will start selling drugs. Agarwal also highlights that procuring generics is a problem in India, as domestic manufacturing is not robust. He cites the example Jan Aushadhi Stores where generics are sold at lower prices. At any time, only 200 of the 600 drugs that the government planned to sell at the Pradhan Mantri Jan Aushadhi Store are available. There has never been a day when all 600 drugs are there. The Bureau of Pharma PSUs of India (BPPI) is the nodal implementation agency for this programme.

This is not the first time the government has planned such a policy. In 1978, there was a similar attempt which the pharmaceutical industry had challenged in court.



(c) International 2006-2017, SANA Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Apr 25: Skin Infections: Focus on Cellulitis & MRSA
Last Chance
Apr 26: Medical Marijuana: Examining the Science, Not the Politics
Apr 27: What's New? New Treatments for Type 2 Diabetes
Apr 30: Using Effective Communication to Reduce Medication Errors
May 01: The New Hypertension Guidelines: What are They Telling Us?
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415